Literature DB >> 33138634

Radiological Society of North America (RSNA) Expert Consensus Statement Related to Chest CT Findings in COVID-19 Versus CO-RADS: Comparison of Reporting System Performance Among Chest Radiologists and End-User Preference.

Siobhan B O' Neill1,2, Danielle Byrne1,2, Nestor L Müller1,2, Sabeena Jalal1, William Parker1,2, Savvas Nicolaou1,2, Ana-Maria Bilawich1,2.   

Abstract

PURPOSE: The RSNA expert consensus statement and CO-RADS reporting system assist radiologists in describing lung imaging findings in a standardized manner in patients under investigation for COVID-19 pneumonia and provide clarity in communication with other healthcare providers. We aim to compare diagnostic performance and inter-/intra-observer among chest radiologists in the interpretation of RSNA and CO-RADS reporting systems and assess clinician preference.
METHODS: Chest CT scans of 279 patients with suspected COVID-19 who underwent RT-PCR testing were retrospectively and independently examined by 3 chest radiologists who assigned interpretation according to the RSNA and CO-RADS reporting systems. Inter-/intra-observer analysis was performed. Diagnostic accuracy of both reporting systems was calculated. 60 clinicians participated in a survey to assess end-user preference of the reporting systems.
RESULTS: Both systems demonstrated almost perfect inter-observer agreement (Fleiss kappa 0.871, P < 0.0001 for RSNA; 0.876, P < 0.0001 for CO-RADS impressions). Intra-observer agreement between the 2 scoring systems using the equivalent categories was almost perfect (Fleiss kappa 0.90-0.92, P < 0.001). Positive predictive values were high, 0.798-0.818 for RSNA and 0.891-0.903 CO-RADS. Negative predictive value were similar, 0.573-0.585 for RSNA and 0.573-0.58 for CO-RADS. Specificity differed between the 2 systems, 68-73% for CO-RADS and 52-58% for RSNA with superior specificity of CO-RADS. Of 60 survey participants, the majority preferred the RSNA reporting system rather than CO-RADS for all options provided (66.7-76.7%; P < 0.05).
CONCLUSIONS: RSNA and CO-RADS reporting systems are consistent and reproducible with near perfect inter-/intra-observer agreement and excellent positive predictive value. End-users preferred the reporting language in the RSNA system.

Entities:  

Keywords:  X-ray computed; adult; coronavirus disease 2019; lung/diagnostic imaging; retrospective studies; tomography

Mesh:

Year:  2020        PMID: 33138634     DOI: 10.1177/0846537120968919

Source DB:  PubMed          Journal:  Can Assoc Radiol J        ISSN: 0846-5371            Impact factor:   2.248


  4 in total

Review 1.  Thoracic imaging tests for the diagnosis of COVID-19.

Authors:  Sanam Ebrahimzadeh; Nayaar Islam; Haben Dawit; Jean-Paul Salameh; Sakib Kazi; Nicholas Fabiano; Lee Treanor; Marissa Absi; Faraz Ahmad; Paul Rooprai; Ahmed Al Khalil; Kelly Harper; Neil Kamra; Mariska Mg Leeflang; Lotty Hooft; Christian B van der Pol; Ross Prager; Samanjit S Hare; Carole Dennie; René Spijker; Jonathan J Deeks; Jacqueline Dinnes; Kevin Jenniskens; Daniël A Korevaar; Jérémie F Cohen; Ann Van den Bruel; Yemisi Takwoingi; Janneke van de Wijgert; Junfeng Wang; Elena Pena; Sandra Sabongui; Matthew Df McInnes
Journal:  Cochrane Database Syst Rev       Date:  2022-05-16

2.  Radiological Findings in SARS-CoV-2 Viral Pneumonia Compared to Other Viral Pneumonias: A Single-Centre Study.

Authors:  Rana Günöz Cömert; Eda Cingöz; Sevim Meşe; Görkem Durak; Atadan Tunaci; Ali Ağaçfidan; Mustafa Önel; Şükrü Mehmet Ertürk
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-09-29       Impact factor: 2.585

Review 3.  COVID-19 pandemic in flu season. Chest computed tomography - what we know so far.

Authors:  Marcin Stański; Łukasz Gąsiorowski; Mateusz Wykrętowicz; Natalia Krystyna Majewska; Katarzyna Katulska
Journal:  Pol J Radiol       Date:  2021-12-31

4.  Diagnostic performance of the RSNA-proposed classification for COVID-19 pneumonia versus pre-pandemic controls.

Authors:  Cauã O Rocha; Tássia A D Prioste; Carlo S Faccin; Luciano Folador; Mateus S Tonetto; Pedro G Knijnik; Natalia B Mainardi; Rogério B Borges; Tiago S Garcia
Journal:  Braz J Infect Dis       Date:  2021-12-18       Impact factor: 1.949

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.